Island Pharmaceuticals Share Price and Company Fundamentals



Price
$0.19
Change
0.000 (0.000%)
52 week
0.115 - 0.385

Last traded: Yesterday at 5:20 AM

Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; research collaboration agreement with Compounds Australia, a drug library containing approximately four and a half thousand molecules that could be searched for drug re-purposing and pipeline development; cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was founded in 2017 and is based in Camberwell, Australia.

Key Metrics

PE ratio

-

PB ratio

2.80

Dividend yield

0.00%

Beta

-

Market cap

-

Enterprise value

-

Company profile

Primary activitiesIsland is a drug development and repurposing company, focused on repurposing and clinical development solutions for viral diseases with no existing therapies.
Industry / SectorBiotechnology / Healthcare
Websitehttps://www.islandpharmaceuticals.com
Mailing address697 Burke Road Suite 201 Camberwell VIC 3124 Australia
Phone / Fax61 3 7036 7675 /
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Island Pharmaceuticals Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Island Pharmaceuticals paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ILA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

ILA's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Island Pharmaceuticals.

NameTitleAgeTotal Pay
Dr. Paul Donald Richard MacLeman M.B.A., MBA, BVSc, Grad Dip Tech, Grad Cert Eng, GExec. Chairman5560.45k
Dr. David Charles FosterMD, CEO, Pres & Exec. Director77.94k
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICDCompany Sec.58

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

0.00%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Island Pharmaceuticals is and its enterprise value is .

Companies similar to Island Pharmaceuticals (ILA)

Island Pharmaceuticals (ASX:ILA) Frequently Asked Questions

1. What is Island Pharmaceuticals's Stock Symbol?

Island Pharmaceuticals trades on ASX under the ticker symbol "ILA".

2. What is Island Pharmaceuticals's stock price today?

One share of ILA stock can currently be purchased for approximately $0.19.

3. How can I contact Island Pharmaceuticals?

Island Pharmaceuticals's mailing address is 697 Burke Road Suite 201 Camberwell VIC 3124 Australia. The company can be reached via phone at 61 3 7036 7675.

4. What is Island Pharmaceuticals's official website?

The official website of Island Pharmaceuticals is https://www.islandpharmaceuticals.com.

5. Which share registry manages Island Pharmaceuticals's stock?

Island Pharmaceuticals's stock is managed by AUTOMIC REGISTRY SERVICES.